Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
Abstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-12-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.12966 |
_version_ | 1818977081705365504 |
---|---|
author | Bin Dong Xin He Ruicong Xue Yili Chen Jingjing Zhao Wengen Zhu Weihao Liang Zexuan Wu Dexi Wu Huiling Huang Yuanyuan Zhou Yugang Dong Chen Liu |
author_facet | Bin Dong Xin He Ruicong Xue Yili Chen Jingjing Zhao Wengen Zhu Weihao Liang Zexuan Wu Dexi Wu Huiling Huang Yuanyuan Zhou Yugang Dong Chen Liu |
author_sort | Bin Dong |
collection | DOAJ |
description | Abstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT). A total of 1714 patients with HFpEF were analysed in our study. In the multivariate Cox proportional hazards regression analysis, history of chronic obstructive pulmonary disease (COPD), smoking, bone fracture after the age of 45, and previous HF hospitalization were identified as independent risk factors for pulmonary hospitalization. To evaluate the prognostic significance of pulmonary hospitalization, patients were categorized into five groups according to the causes of their first hospitalization. The all‐cause and cardiovascular (CV) mortality risks in these five groups were compared using time‐varying Cox proportional hazards model. Compared with patients without hospitalization during follow‐up, those with pulmonary hospitalization were associated with a 204% increase [hazard ratio (HR) 3.04, 95% confidence interval (CI) 2.07–4.47, P < 0.001] and 164% increase (HR 2.64, 95% CI 1.60–4.36, P < 0.001) in risks of all‐cause and CV mortality, respectively, while the corresponding risk increases associated with HF hospitalization were 146% (HR 2.46, 95% CI 1.74–3.48, P < 0.001) for all‐cause mortality and 186% (HR 2.86, 95% CI 1.87–4.36, P < 0.001) for CV mortality. Conclusions Pulmonary hospitalization was associated with a significant increase in risks of all‐cause and CV mortality, which was comparable with that associated with HF hospitalization. The results suggested that pulmonary hospitalization could be another important clinical endpoint of HFpEF. |
first_indexed | 2024-12-20T16:22:04Z |
format | Article |
id | doaj.art-06806c4493dc42c78e3b4d87bd375c63 |
institution | Directory Open Access Journal |
issn | 2055-5822 |
language | English |
last_indexed | 2024-12-20T16:22:04Z |
publishDate | 2020-12-01 |
publisher | Wiley |
record_format | Article |
series | ESC Heart Failure |
spelling | doaj.art-06806c4493dc42c78e3b4d87bd375c632022-12-21T19:33:35ZengWileyESC Heart Failure2055-58222020-12-01763801380910.1002/ehf2.12966Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCATBin Dong0Xin He1Ruicong Xue2Yili Chen3Jingjing Zhao4Wengen Zhu5Weihao Liang6Zexuan Wu7Dexi Wu8Huiling Huang9Yuanyuan Zhou10Yugang Dong11Chen Liu12Department of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaAbstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT). A total of 1714 patients with HFpEF were analysed in our study. In the multivariate Cox proportional hazards regression analysis, history of chronic obstructive pulmonary disease (COPD), smoking, bone fracture after the age of 45, and previous HF hospitalization were identified as independent risk factors for pulmonary hospitalization. To evaluate the prognostic significance of pulmonary hospitalization, patients were categorized into five groups according to the causes of their first hospitalization. The all‐cause and cardiovascular (CV) mortality risks in these five groups were compared using time‐varying Cox proportional hazards model. Compared with patients without hospitalization during follow‐up, those with pulmonary hospitalization were associated with a 204% increase [hazard ratio (HR) 3.04, 95% confidence interval (CI) 2.07–4.47, P < 0.001] and 164% increase (HR 2.64, 95% CI 1.60–4.36, P < 0.001) in risks of all‐cause and CV mortality, respectively, while the corresponding risk increases associated with HF hospitalization were 146% (HR 2.46, 95% CI 1.74–3.48, P < 0.001) for all‐cause mortality and 186% (HR 2.86, 95% CI 1.87–4.36, P < 0.001) for CV mortality. Conclusions Pulmonary hospitalization was associated with a significant increase in risks of all‐cause and CV mortality, which was comparable with that associated with HF hospitalization. The results suggested that pulmonary hospitalization could be another important clinical endpoint of HFpEF.https://doi.org/10.1002/ehf2.12966Heart failure with preserved ejection fractionPulmonary hospitalizationRisk factorsPrognosis |
spellingShingle | Bin Dong Xin He Ruicong Xue Yili Chen Jingjing Zhao Wengen Zhu Weihao Liang Zexuan Wu Dexi Wu Huiling Huang Yuanyuan Zhou Yugang Dong Chen Liu Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT ESC Heart Failure Heart failure with preserved ejection fraction Pulmonary hospitalization Risk factors Prognosis |
title | Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT |
title_full | Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT |
title_fullStr | Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT |
title_full_unstemmed | Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT |
title_short | Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT |
title_sort | clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction from the topcat |
topic | Heart failure with preserved ejection fraction Pulmonary hospitalization Risk factors Prognosis |
url | https://doi.org/10.1002/ehf2.12966 |
work_keys_str_mv | AT bindong clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT xinhe clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT ruicongxue clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT yilichen clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT jingjingzhao clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT wengenzhu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT weihaoliang clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT zexuanwu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT dexiwu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT huilinghuang clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT yuanyuanzhou clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT yugangdong clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat AT chenliu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat |